We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

VISN Collaborative for Improving Hypertension Management With ATHENA-HTN

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00374452
First Posted: September 11, 2006
Last Update Posted: April 28, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
VA Office of Research and Development
  Purpose
This project is a VA HSR&D-funded Quality Enhancement Research Initiative (QUERI) project to translate into practice evidence about clinical management of primary hypertension. The project aims to contribute to quality improvement of care for patients with primary hypertension. The project will implement a clinical decision support system for primary care clinicians and will evaluate the implementation by studying the impact on the clinicians' prescribing and their patients' blood pressures, and will also study organizational factors.

Condition Intervention
Hypertension Behavioral: ATHENA-Hypertension clinical decision support system

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Official Title: VISN Collaborative for Improving Hypertension Management With ATHENA-HTN

Further study details as provided by VA Office of Research and Development:

Primary Outcome Measures:
  • Primary care clinician (health professional) adherence to guideline-recommended management of hypertension Blood pressures for patients of the primary care clinicians [ Time Frame: 6 months, 12 months ]
    The primary outcome is intensification of therapy for hypertension when the patient's blood pressure is above target. Alternate events that we plan to track include: achieving target BP prior to intensification of therapy; return visits with continued blood pressure above target or blood pressure not measured and no intensification of therapy (undesired outcome). The enrollment number 103 is the number of primary careproviders who started the intervention phase of the trial at their study site.


Secondary Outcome Measures:
  • Primary care clinician use of ATHENA decision support system. Prescribing of thiazide diuretics when appropriate; appropriate return intervals for patients with blood pressure not well controlled. Patient medication adherence per pharmacy refill records. [ Time Frame: 12 months, clinician use of the ATHENA decision support system 6 months ]

Enrollment: 103
Study Start Date: January 2007
Study Completion Date: March 2011
Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Arm 1
ATHENA display providing guideline-based recommendations to clinicians at the time of patient care. Link to JNC7 guidelines.
Behavioral: ATHENA-Hypertension clinical decision support system
ATHENA display provides guideline-based recommendations to clinicians at the time of patient care.
No Intervention: Arm 2
Link to JNC7 and to VA-DoD hypertension guidelines

  Show Detailed Description

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Must be primary care clinicians (for example, physician or nurse practitioner) at one of the participating VA medical centers. This study is NOT recruiting patients.
  • The primary care clinician must have a panel of patients for whom he or she provides direct care.

Exclusion Criteria:

  • Anyone who does not meet inclusion criteria.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00374452


Locations
United States, California
VA Palo Alto Health Care System
Palo Alto, California, United States, 94304
United States, Connecticut
VA Connecticut Health Care System (Newington)
Newington, Connecticut, United States, 06111
VA Connecticut Health Care System (West Haven)
West Haven, Connecticut, United States, 06516
United States, Massachusetts
Edith Nourse Rogers Memorial Veterans Hospital, Bedford
Bedford, Massachusetts, United States, 01730
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Boston, Massachusetts, United States, 02130
United States, New Hampshire
VA Medical Center, Manchester
Manchester, New Hampshire, United States, 03104
United States, Rhode Island
VA Medical Center, Providence
Providence, Rhode Island, United States, 02908
Sponsors and Collaborators
VA Office of Research and Development
Investigators
Principal Investigator: Mary K. Goldstein, MD MS VA Palo Alto Health Care System
  More Information

Publications:

Responsible Party: VA Office of Research and Development
ClinicalTrials.gov Identifier: NCT00374452     History of Changes
Other Study ID Numbers: IMV 04-062
First Submitted: September 8, 2006
First Posted: September 11, 2006
Last Update Posted: April 28, 2014
Last Verified: April 2014

Keywords provided by VA Office of Research and Development:
hypertension
practice guidelines
quality of health care
decision support systems
evidence-based medicine
medical informatics

Additional relevant MeSH terms:
Hypertension
Vascular Diseases
Cardiovascular Diseases